EU reopens its borders to 14 nations but not to US tourists

The European Union announced Tuesday that it will reopen its borders to travelers from 14 countries, but most Americans have been refused entry for at least another two weeks. (Reuters/File Photo)
Short Url
Updated 30 June 2020

EU reopens its borders to 14 nations but not to US tourists

  • Travelers from other big countries like Russia, Brazil and India will also miss out

BRUSSELS: The European Union announced Tuesday that it will reopen its borders to travelers from 14 countries, but most Americans have been refused entry for at least another two weeks due to soaring coronavirus infections in the U.S.
Travelers from other big countries like Russia, Brazil and India will also miss out.
Citizens from the following countries will be allowed into the EU's 27 members and four other nations in Europe's visa-free Schengen travel zone: Algeria, Australia, Canada, Georgia, Japan, Montenegro, Morocco, New Zealand, Rwanda, Serbia, South Korea, Thailand, Tunisia and Uruguay.
The EU said China is “subject to confirmation of reciprocity,” meaning it must lift all restrictions on European citizens entering China before it will allow Chinese citizens back in.
Countries considered for the safe list are also expected to lift any bans they might have in place on European travelers.
As Europe’s economies reel from the impact of the coronavirus, southern EU countries like Greece, Italy and Spain are desperate to entice back sun-loving visitors and breathe life into their damaged tourism industries.
More than 15 million Americans are estimated to travel to Europe each year, while some 10 million Europeans head across the Atlantic.
Still, many people both inside and outside Europe remain wary of travel in the coronavirus era, given the unpredictability of the pandemic and the possibility of second waves of infection that could affect flights and hotel bookings. Tens of thousands of travelers had a frantic, chaotic scramble in March to get home as the pandemic swept across the world and borders slammed shut.
EU envoys to Brussels have launched a written procedure which would see the list endorsed Tuesday as long as no objections are raised by member countries. The list is expected to contain up to 15 countries that have virus infection rates comparable to those in the EU.
The countries would also have to lift any bans they might have on European travelers. The list of permitted nations is to be updated every 14 days, with new countries being added or even dropping off depending on if they are keeping the disease under control.
The daily number of new confirmed cases in the United States has surged over the past week. The US has the world’s worst coronavirus outbreak, with nearly 2.6 million people confirmed infected and over 126,000 dead, according to a tally by Johns Hopkins University that experts say understates the pandemic’s true toll due to limited testing and other reasons.
In contrast, aside from a notable recent outbreak tied to a slaughterhouse in western Germany, the virus’s spread has generally stabilized across much of continental Europe.
In March, President Donald Trump suspended all people from Europe’s ID check-free travel zone from entering the U.S., making it unlikely now that U.S. citizens would qualify to enter the EU.
The EU imposed restrictions on non-essential travel to its 27 nations, plus Iceland, Liechtenstein, Norway and Switzerland, which are part of the Schengen open-borders area, in March to halt the spread of the virus. Non-EU citizens who are already living in Europe are not included in the ban.
The EU list does not apply to travel to Britain, which left the EU in January. Britain now requires all incoming travelers — bar a few exceptions like truck drivers — to go into a self-imposed 14-day quarantine, although the measure is under review and is likely to ease in the coming weeks. The requirement also applies to UK citizens.


US to pay over $1bn for 100m doses of J&J’s potential COVID-19 vaccine

Updated 05 August 2020

US to pay over $1bn for 100m doses of J&J’s potential COVID-19 vaccine

  • The latest contract equates to roughly $10 per vaccine dose produced by J&J
  • This is J&J’s first deal to supply its investigational vaccine to a country

WASHINGTON: The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday.
It said it would deliver the vaccine to the Biomedical Advanced Research and Development Authority (BARDA) on a not-for-profit basis to be used after approval or emergency use authorization by the US Food and Drug Administration (FDA).
J&J has already received $1 billion in funding from the US government — BARDA agreed in March to provide that money for the company to build manufacturing capacity for more than 1 billion doses of the experimental vaccine.
The latest contract equates to roughly $10 per vaccine dose produced by J&J. Including the first $1 billion deal with the USgovernment, the price would be slightly higher than the $19.50 per dose that the United States is paying for the vaccine being developed by Pfizer Inc. and German biotech BioNTech SE.
The US government may also purchase an additional 200 million doses under a subsequent agreement. J&J did not disclose that deal’s value.
J&J plans to study a one- or two-dose regimen of the vaccine in parallel later this year. A single-shot regimen could allow more people to be vaccinated with the same number of doses and would sidestep issues around getting people to come back for their second dose.
This is J&J’s first deal to supply its investigational vaccine to a country. Talks are underway with the European Union, but no deal has yet been reached.
J&J’s investigational vaccine is currently being tested on healthy volunteers in the United States and Belgium in an early-stage study.
There are currently no approved vaccines for COVID-19. More than 20 are in clinical trials.